Company Profile for Cypress Pharmaceutical, Inc.

Cypress Pharmaceutical, Inc. (“Cypress” or the “Company”), founded in 1993, is a rapidly growing specialty pharmaceutical company that develops, markets and distributes generic prescription pharmaceutical products to the leading national pharmaceutical wholesalers, chain drug stores, distributors, and other retail merchandisers. In 1999, Cypress established a specialty branded business; Hawthorn Pharmaceuticals (“Hawthorn”), to market a line of internally developed pharmaceutical products directly to physician specialties through its nationwide growing sales force, currently at more than 125 sales professionals.

The Company has an aggressive product development pipeline including new drug applications (“NDAs”), and abbreviated new drug applications (“ANDAs”) with over 35 products in various stages of development. Cypress currently has 7 submissions with the Food and Drug Administration (“FDA”) with up to 20 submissions expected to be filed in 2008.

Cypress and Hawthorn have successfully signed several in-licensing agreements with multinational companies in the past several years and will continue to utilize strategic alliances as part of its overall pharmaceutical pipeline.

Additional information about Cypress and Hawthorn is available at the Company’s websites: www.cypressrx.com and www.hawthornrx.com.

Company:

 

Cypress Pharmaceutical, Inc.

 

Headquarters Address:

Post Office Box 399

135 Industrial Blvd

Madison, MS 39130

 

Main Telephone:

800-856-4393

 

Website:

www.cypressrx.com

 

Type of Organization:

Private

 

Industry:

Pharmaceutical

 

Key Executives:

CEO: Max Draughn

CFO: Jason Sanderson

Executive Vice President: Glenn Pruitt

 

Customer Service

Contact:

Chris Boone

Phone:

800-856-4393

Email:

cboone@cypressrx.com

 

New Product Development

Contact:

Rob Lewis

Phone:

800-856-4393

Email:

rlewis@cypressrx.com

 

Sales

Contact:

Greg Stofko

Phone:

800-856-4393

Email:

gstofko@cypressrx.com